UCLA Health: How a CRISPR Sickle Cell Therapy Moved From Lab to Clinical Trial
November 05, 2026
November 05, 2026
LOS ANGELES, California, Nov. 5 (TNSjou) -- The UCLA Health issued the following news release:
* * *
How a CRISPR sickle cell therapy moved from lab to clinical trial
UCLA scientists detail the manufacturing and safety testing behind a gene-edited stem cell therapy now in a phase 1 clinical trial
November 3, 2026
Findings
A UCLA-led team has described how they advanced an experimental CRISPR approach for sickle cell di . . .
* * *
How a CRISPR sickle cell therapy moved from lab to clinical trial
UCLA scientists detail the manufacturing and safety testing behind a gene-edited stem cell therapy now in a phase 1 clinical trial
November 3, 2026
Findings
A UCLA-led team has described how they advanced an experimental CRISPR approach for sickle cell di . . .